Major depressive disorder and immunity to varicella-zoster virus in the elderly

Brain, Behavior, and Immunity

Volumn 25, Issue 4, 2011, Pages 759-766

  Irwin, Michael R ^a   Levin, Myron J ^b   Carrillo, Carmen ^a   Olmstead, Richard ^a   Lucko, Anne ^d   Lang, Nancy ^b   Caulfield, Michael J ^e   Weinberg, Adriana ^d   Chan, Ivan S F ^e   Clair, Jim ^e   Smith, Jeff G ^e   Marchese, R D ^e   Williams, Heather M ^d   Beck, Danielle J ^d   McCook, Patricia T ^d   Johnson, Gary ^c   Oxman, Michael N ^d,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VA Cooperative Studies Program Coordinating Center   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell mediated immunity; Elderly; Herpes zoster; Human; Infectious disease; Major depression; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; GAMMA INTERFERON; GLYCOPROTEIN; VIRUS VACCINE;

AGED; ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS;

EID: 79954743982     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.001     Document Type: Article

References (54)

1. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory Manual 1996, Psychological Corporation, San Antonio, TX.
2. Berger R., Florent G., Just M. Decrease of the lymphoprolifertive response to varicella-zoster virus antigen in the aged. Infection and Immunity 1981, 32:24-27.
3. Burke B.L., Steele R.W., Beard O.W., Wood J.S., Cain T.D., Marmer D.J. Immune response to varicella-zoster in the aged. Arch. Intern. Med. 1982, 142:291-293.
4. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
5. Cohen F., Kemeny M.E., Kearney K.A., Zegans L.S., Neuhaus J.M., Conant M.A. Persistent stress as a predictor of genital herpes recurrence. Arch. Intern. Med. 1999, 159:2430-2436.
6. Cohen S., Doyle W.J., Alper C.M., Janicki-Deverts D., Turner R.B. Sleep habits and susceptibility to the common cold. Arch. Intern. Med. 2009, 169:62-67.
7. Cole S.W., Kemeny M.E., Fahey J.L., Zack J.A., Naliboff B.D. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol. Psychiatry 2003, 54:1444-1456.
8. Cruess D.G., Douglas S.D., Petitto J.M., Have T.T., Gettes D., Dube B., Cary M., Evans D.L. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am. J. Psychiatry 2005, 162:2125-2130.
9. Donahue J.G., Choo P.W., Manson J.E., Platt R. The incidence of herpes zoster. Arch. Intern. Med. 1995, 155:1605-1609.
10. Evans D.L., Lynch K.G., Benton T., Dube B., Gettes D.R., Tustin N.B., Lai J.P., Metzger D., Douglas S.D. Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol. Psychiatry 2008, 63:899-905.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition, Version 2.0 1996, New York State Psychiatric Institute, New York, NY.
12. Gilden D.H., Kleinschmidt-DeMasters B.K., LaGuardia J.J., Mahalingam R., Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 2000, 342:635-645.
13. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
14. Glaser R., Pearson G.R., Bonneau R.H., Esterling B.A., Atkinson C., Kiecolt-Glaser J.K. Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students. Health Psychol. 1993, 12:435-442.
15. Gnann J.W., Whitley R.J. Clinical practice Herpes zoster. N. Engl. J. Med. 2002, 347:340-346.
16. Hammond O., Wang Y., Green T., Antonello J., Kuhn R., Motley C., Stump P., Rich B., Chirmule N., Marchese R.D. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. J. Med. Virol. 2006, 78:1679-1687.
17. Harpaz, R., Ortega-Sanchez, I.R., Seward, J.F., 2008. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 57, 1-30; quiz CE32-34.
18. Hayward A.R. In vitro measurement of human T cell responses to varicella zoster virus antigen. Arch. Virol. Suppl. 2001, 143:149.
19. Hayward A.R., Zerbe G.O., Levin M.J. Clinical application of responder cell frequency estimates with four years of follow up. J. Immunol. Methods 1994, 170:27-36.
20. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 1965, 58:9.
21. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
22. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., Nikas A.A. The incidence of herpes zoster in a United States administrative database. J. Gen. Intern. Med. 2005, 20:748-753.
23. Irwin M., Artin K.H., Oxman M.N. Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch. Intern. Med. 1999, 159:1701-1704.
24. Irwin M., Costlow C., Williams H., Artin K.H., Chan C.Y., Stinson D.L., Levin M.J., Hayward A.R., Oxman M.N. Cellular immunity to varicella-zoster virus in patients with major depression. J. Infect. Dis. 1998, 178(Suppl. 1):S104-S108.
25. Irwin M., McClintick J., Costlow C., Fortner M., White J., Gillin J.C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996, 10:643-653.
26. Irwin M., Patterson T., Smith T.L., Caldwell C., Brown S.A., Gillin J.C., Grant I. Reduction of immune function in life stress and depression. Biol. Psychiatry 1990, 27:22-30.
27. Irwin M.R. Human psychoneuroimmunology: 20 years of discovery. Brain Behav. Immun. 2008, 22:129-139.
28. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 2007, 21:374-383.
29. Irwin M.R., Olmstead R., Oxman M.N. Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi. J. Am. Geriatr. Soc. 2007, 55:511-517.
30. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 2006, 166:1756-1762.
31. Irwin M.R., Wang M., Ribeiro D., Cho H.J., Olmstead R., Breen E.C., Martinez-Maza O., Cole S. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 2008, 64:538-540.
32. Kiecolt-Glaser J.K., Glaser R., Gravenstein S., Malarkey W.B. Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc. Natl. Acad. Sci. 1996, 93:3043-3047.
33. Levin M.J., Murray M., Rotbart H.A., Zerbe G.O., White C.J., Hayward A.R. Immune response of elderly individuals to a live-attenuated varicella vaccine. J. Infect. Dis. 1992, 166:253-259.
34. Levin M.J., Oxman M.N., Zhang J.H., Johnson G.R., Stanley H., Hayward A.R., Caulfield M.J., Irwin M.R., Smith J.G., Clair J., Chan I.S., Williams H., Harbecke R., Marchese R., Straus S.E., Gershon A., Weinberg A. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J. Infect. Dis. 2008, 197:825-835.
35. Li S., Chan I.S., Matthews H., Heyse J.F., Chan C.Y., Kuter B.J., Kaplan K.M., Vessey S.J., Sadoff J.C. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr. Infect. Dis. J. 2002, 21:337-342.
36. Miller A.E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980, 30:582-587.
37. O'Connor, M.F., Bower, J.E., Cho, H.J., Creswell, J.D., Dimitrov, S., Hamby, M.E., Hoyt, M.A., Martin, J.L., Robles, T.F., Sloan, E.K., Thomas, K.S., Irwin, M.R., 2009. To assess to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun.
38. Oxman, M.N., xxxx. Zoster vaccine: current status and future prospects. Clin. Infect. Dis. 51, 197-213.
39. Oxman M.N., Alani R. Varicella and Herpes Zoster. Dermatology in General Medicine 1993, 2543-2572. McGraw-Hill Book Co., New York. T.B. Fitzpatrick (Ed.).
40. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., Arbeit R.D., Simberkoff M.S., Gershon A.A., Davis L.E., Weinberg A., Boardman K.D., Williams H.M., Zhang J.H., Peduzzi P.N., Beisel C.E., Morrison V.A., Guatelli J.C., Brooks P.A., Kauffman C.A., Pachucki C.T., Neuzil K.M., Betts R.F., Wright P.F., Griffin M.R., Brunell P., Soto N.E., Marques A.R., Keay S.K., Goodman R.P., Cotton D.J., Gnann J.W., Loutit J., Holodniy M., Keitel W.A., Crawford G.E., Yeh S.S., Lobo Z., Toney J.F., Greenberg R.N., Keller P.M., Harbecke R., Hayward A.R., Irwin M.R., Kyriakides T.C., Chan C.Y., Chan I.S., Wang W.W., Annunziato P.W., Silber J.L. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 2005, 352:2271-2284.
41. Pike J.L., Irwin M.R. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav. Immun. 2006, 20:169-174.
42. Ragozzino M.W., Melton L.J., Kurland L.T., Chu C.P., Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine 1982, 61:310-316.
43. Schleifer S.J., Keller S.E., Bond R.N., Cohen J., Stein M. Major depressive disorder and immunity: role of age, sex, severity, and hospitalization. Arch. Gen. Psychiatry 1989, 46:81-87.
44. Schmader K., George L.K., Burchett B.M., Hamilton J.D., Pieper C.F. Race and stress in the incidence of herpes zoster in older adults. J. Am. Geriatr. Soc. 1998, 46:973-977.
45. Schmader K., George L.K., Burchett B.M., Pieper C.F. Racial and psychosocial risk factors for herpes zoster in the elderly. J. Infect. Dis. 1998, 178(Suppl. 1):S67-S70.
46. Schmader K.E., Studenski S., MacMillan J., Grufferman S., Cohen H.J. Are stressful life events risk factors for herpes zoster?. Am. J. Geriatr. Soc. 1990, 38:1188-1195.
47. Smith J.G., Liu X., Kaufhold R.M., Clair J., Caulfield M.J. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin. Diagn. Lab. Immunol. 2001, 8:871-879.
48. Spitzer R.L., Williams J.B.W., Gibbon M. Structure Clinical Interview for DSM-IIIR (SCID) 1987, Biometrics Research, New York.
49. Tucker P., Ruwe W.D., Masters B., Parker D.E., Hossain A., Trautman R.P., Wyatt D.B. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol. Psychiatry 2004, 56:121-128.
50. Vedhara K., Cox N.K., Wilcock G.K., Perks P., Hunt M., Anderson S., Lightman S.L., Shanks N.M. Chronic stress in elderly careers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353:627-631. (see comments).
51. von Korff M., Wagner E.H., Saunders K. A chronic disease score from automated pharmacy data. J. Clin. Epidem. 1992, 45:197-203.
52. Weinberg A., Zhang J.H., Oxman M.N., Johnson G.R., Hayward A.R., Caulfield M.J., Irwin M.R., Clair J., Smith J.G., Stanley H., Marchese R.D., Harbecke R., Williams H.M., Chan I.S., Arbeit R.D., Gershon A.A., Schodel F., Morrison V.A., Kauffman C.A., Straus S.E., Schmader K.E., Davis L.E., Levin M.J., Investigators of the SPS Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J. Infect. Dis. 2009, 200:1068-1077.
53. Yawn B.P., Saddier P., Wollan P.C., St.Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin. Proc. 2007, 82:1341-1349.
54. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 2001, 15:199-226.